-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Zimmer Biomet Holdings, Raises Price Target to $120

Benzinga·11/06/2026 00:23:12
JP Morgan analyst Robbie Marcus maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and raises the price target from $117 to $120.